$SNDA

According to Finnhub, Sanderson Design Group (SNDA) is set to report Q2 2026 earnings on Aug. 10 before market open. Analysts expect revenue of $213.56M and EPS of -$1.18. The article cites Q1 2026 revenue of $122.6M (+33.41% YoY), recent insider purchases, institutional position changes, and a median $40.0 price target.

Biotech and healthcare stocks hit 52-week highs on July 27, 2026. Dyne Therapeutics (DYN) rose over 5% to $26.12 after FDA accepted its Z-Rostudirsen BLA; it raised $431m. Sonida Senior Living (SNDA) reached $44.38 after its CHP acquisition. Silence Therapeutics (SLN) hit $12.19. Amylyx (AMLX) rose to $19.60. Labcorp (LH) climbed to $301.7 after launching a genetic testing platform; Q1 revenue was $3.54b and 2026 revenue guidance $14.65b-$14.80b.

A roundup of Monday analyst actions across many stocks. Piper Sandler upgraded Rivian (RIVN) and Mobileye (MBLY) to overweight, and initiated Williams-Sonoma (WSM) overweight with a $253 target. Other calls include Alphabet (GOOGL) buy, Cameco (CCJ) buy, Nvidia (NVDA) outperform, Apple (AAPL) buy with $370 target, and Tesla (TSLA) buy with $420 target.

Sunda Energy Plc (AIM: SNDA) said Alumni Capital will convert £100,000 of drawn principal plus a £10,000 finance charge under its convertible loan notes into 11,763,447 new 0.1p ordinary shares at 0.9351p per share. The conversion also grants 6,786,604 warrants at a 30% premium. AIM admission is expected around 20 July 2026.

RBC Capital raised its price target on Sonida Senior Living (NYSE:SNDA) to $48 from $45 and kept an Outperform rating, citing improved reflection of momentum as the company enters a compounding growth phase. Sonida also appointed Anton Nikodemus as Chief Operating Officer effective June 15, 2026. Morgan Stanley earlier lifted its target to $38 from $31.

Proactive’s small-cap snapshot covers ACG Metals (LSE:ACG, OTC:ACGAF), which beat its full-year oxide production target in six months, with realised gold price up 64% to $4,838/oz and first copper and zinc concentrate due in August. Rockfire Resources (LSE:ROCK) reports high zinc grades at Molaoi. Sunda Energy (AIM:SNDA) applies to explore New Zealand’s Taranaki Basin. CelLBxHealth (AIM:CLBX) targets at least £2.1m revenue. Poolbeg Pharma (AIM:POLB) raises £3.5m for trials.

The article highlights 10 growth stocks with increased insider ownership, using a Finviz screen and criteria including at least 20% compounded earnings growth over three years. It cites analyst actions and company updates for Sonida Senior Living (SNDA) and Zura Bio (ZURA), including SNDA price target raises to $48 and ZURA Phase 2 enrollment and $225.6M cash.

SONIDA SENIOR LIVING, INC. (SNDA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001043000 0001043000 2026-06-11 2026-06-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 11, 202

Sunda Energy Plc (LON:SNDA) shares hit a new 52-week low on Thursday, trading as low as 1.60p and last at 1.70p versus a prior close of 1.82p, with 2.21m shares traded. The stock was down 11.1%. The company’s market cap is £5.52m, with a negative P/E of -2.00.

Sonida Senior Living's SVP & Chief Legal Officer, Tabitha Bailey, was granted 55,000 performance units (PSUs) which can convert to common stock, conditional on stockholder approval for increasing the 2019 Plan share reserve and the company's merger with CNL Healthcare Properties. These PSUs are eligible to vest between 33% and 100% from February 23, 2027, to February 23, 2030, based on stock price performance. Additionally, 402 shares were withheld for tax obligations on December 9, 2025, leaving Bailey with 14,913 directly owned shares, and another 5,315 PSUs are eligible to vest based on financial goals after 2027.